Recent advances in the identification and management of inherited hyperoxalurias

David Sas, Peter C Harris, Dawn S. Milliner

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Primary hyperoxaluria (PH) is caused by genetic mutations resulting in oxalate overproduction leading to nephrolithiasis, nephrocalcinosis, extrarenal manifestations, chronic kidney disease, and end-stage renal disease. Advances in genetic testing techniques have improved our ability to efficiently and effectively obtain a definitive diagnosis of PH as well as easily screen at-risk family members. Similarly, advances in technologies related to intervening at the genetic and molecular level promise to change the way we treat patients with PH. In this review, we provide an update regarding the identification of underlying molecular and biochemical causes of inherited hyperoxalurias, clinical manifestations, and treatment strategies.

Original languageEnglish (US)
JournalUrolithiasis
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Primary Hyperoxaluria
Hyperoxaluria
Nephrocalcinosis
Genetic Techniques
Nephrolithiasis
Aptitude
Oxalates
Genetic Testing
Chronic Renal Insufficiency
Chronic Kidney Failure
Molecular Biology
Technology
Mutation
Therapeutics

Keywords

  • Genetic
  • Kidney stones
  • Nephrolithiasis
  • Primary hyperoxaluria

ASJC Scopus subject areas

  • Urology

Cite this

Recent advances in the identification and management of inherited hyperoxalurias. / Sas, David; Harris, Peter C; Milliner, Dawn S.

In: Urolithiasis, 01.01.2018.

Research output: Contribution to journalArticle

@article{da12e10dda434a49819a32828be8f021,
title = "Recent advances in the identification and management of inherited hyperoxalurias",
abstract = "Primary hyperoxaluria (PH) is caused by genetic mutations resulting in oxalate overproduction leading to nephrolithiasis, nephrocalcinosis, extrarenal manifestations, chronic kidney disease, and end-stage renal disease. Advances in genetic testing techniques have improved our ability to efficiently and effectively obtain a definitive diagnosis of PH as well as easily screen at-risk family members. Similarly, advances in technologies related to intervening at the genetic and molecular level promise to change the way we treat patients with PH. In this review, we provide an update regarding the identification of underlying molecular and biochemical causes of inherited hyperoxalurias, clinical manifestations, and treatment strategies.",
keywords = "Genetic, Kidney stones, Nephrolithiasis, Primary hyperoxaluria",
author = "David Sas and Harris, {Peter C} and Milliner, {Dawn S.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1007/s00240-018-1093-3",
language = "English (US)",
journal = "Urolithiasis",
issn = "2194-7228",
publisher = "Springer Verlag",

}

TY - JOUR

T1 - Recent advances in the identification and management of inherited hyperoxalurias

AU - Sas, David

AU - Harris, Peter C

AU - Milliner, Dawn S.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Primary hyperoxaluria (PH) is caused by genetic mutations resulting in oxalate overproduction leading to nephrolithiasis, nephrocalcinosis, extrarenal manifestations, chronic kidney disease, and end-stage renal disease. Advances in genetic testing techniques have improved our ability to efficiently and effectively obtain a definitive diagnosis of PH as well as easily screen at-risk family members. Similarly, advances in technologies related to intervening at the genetic and molecular level promise to change the way we treat patients with PH. In this review, we provide an update regarding the identification of underlying molecular and biochemical causes of inherited hyperoxalurias, clinical manifestations, and treatment strategies.

AB - Primary hyperoxaluria (PH) is caused by genetic mutations resulting in oxalate overproduction leading to nephrolithiasis, nephrocalcinosis, extrarenal manifestations, chronic kidney disease, and end-stage renal disease. Advances in genetic testing techniques have improved our ability to efficiently and effectively obtain a definitive diagnosis of PH as well as easily screen at-risk family members. Similarly, advances in technologies related to intervening at the genetic and molecular level promise to change the way we treat patients with PH. In this review, we provide an update regarding the identification of underlying molecular and biochemical causes of inherited hyperoxalurias, clinical manifestations, and treatment strategies.

KW - Genetic

KW - Kidney stones

KW - Nephrolithiasis

KW - Primary hyperoxaluria

UR - http://www.scopus.com/inward/record.url?scp=85057619866&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057619866&partnerID=8YFLogxK

U2 - 10.1007/s00240-018-1093-3

DO - 10.1007/s00240-018-1093-3

M3 - Article

C2 - 30535828

AN - SCOPUS:85057619866

JO - Urolithiasis

JF - Urolithiasis

SN - 2194-7228

ER -